HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q1 2024. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,965,954 | +269.4% | 46,380 | +267.8% | 0.18% | +259.2% |
| Q2 2023 | $1,073,615 | -80.5% | 12,610 | -81.0% | 0.05% | -81.9% |
| Q1 2023 | $5,501,220 | -27.5% | 66,480 | -31.1% | 0.27% | -31.8% |
| Q4 2022 | $7,584,220 | +0.1% | 96,430 | -5.8% | 0.40% | -6.2% |
| Q3 2022 | $7,576,000 | +40.0% | 102,340 | +23.2% | 0.42% | +45.5% |
| Q2 2022 | $5,413,000 | -42.7% | 83,050 | +0.9% | 0.29% | -23.3% |
| Q4 2019 | $9,455,000 | -34.7% | 82,292 | -28.3% | 0.38% | -36.0% |
| Q3 2019 | $14,487,000 | +4.9% | 114,850 | +0.1% | 0.59% | +11.5% |
| Q2 2019 | $13,808,000 | +21.7% | 114,740 | +1.2% | 0.53% | +9.5% |
| Q4 2018 | $11,347,000 | -39.0% | 113,412 | -30.1% | 0.48% | -9.4% |
| Q3 2018 | $18,587,000 | -8.5% | 162,222 | -28.4% | 0.53% | -14.7% |
| Q2 2018 | $20,322,000 | +18.5% | 226,602 | -3.3% | 0.63% | +15.3% |
| Q1 2018 | $17,145,000 | +62.7% | 234,356 | +29.1% | 0.54% | +71.8% |
| Q4 2017 | $10,541,000 | – | 181,495 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
| Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
| AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
| Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
| SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
| KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
| STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
| HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
| ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
| Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |